These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8921948)

  • 1. Differential activation of human autoreactive T cell clones by altered peptide ligands derived from myelin basic protein peptide (87-99).
    Vergelli M; Hemmer B; Utz U; Vogt A; Kalbus M; Tranquill L; Conlon P; Ling N; Steinman L; McFarland HF; Martin R
    Eur J Immunol; 1996 Nov; 26(11):2624-34. PubMed ID: 8921948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor.
    Madsen LS; Andersson EC; Jansson L; krogsgaard M; Andersen CB; Engberg J; Strominger JL; Svejgaard A; Hjorth JP; Holmdahl R; Wucherpfennig KW; Fugger L
    Nat Genet; 1999 Nov; 23(3):343-7. PubMed ID: 10610182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural basis for the binding of an immunodominant peptide from myelin basic protein in different registers by two HLA-DR2 proteins.
    Li Y; Li H; Martin R; Mariuzza RA
    J Mol Biol; 2000 Nov; 304(2):177-88. PubMed ID: 11080454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered peptide ligands of islet autoantigen Imogen 38 inhibit antigen specific T cell reactivity in human type-1 diabetes.
    Geluk A; van Meijgaarden KE; Roep BO; Ottenhoff TH
    J Autoimmun; 1998 Aug; 11(4):353-61. PubMed ID: 9776713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myelin basic protein-specific T lymphocyte repertoire in multiple sclerosis. Complexity of the response and dominance of nested epitopes due to recruitment of multiple T cell clones.
    Meinl E; Weber F; Drexler K; Morelle C; Ott M; Saruhan-Direskeneli G; Goebels N; Ertl B; Jechart G; Giegerich G
    J Clin Invest; 1993 Dec; 92(6):2633-43. PubMed ID: 7504690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human T cell autoimmunity against myelin basic protein: CD4+ cells recognizing epitopes of the T cell receptor beta chain from a myelin basic protein-specific T cell clone.
    Saruhan-Direskeneli G; Weber F; Meinl E; Pette M; Giegerich G; Hinkkanen A; Epplen JT; Hohlfeld R; Wekerle H
    Eur J Immunol; 1993 Feb; 23(2):530-6. PubMed ID: 7679649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-reactivity of T-cell clones specific for altered peptide ligands of myelin basic protein.
    Ausubel LJ; Bieganowska KD; Hafler DA
    Cell Immunol; 1999 Apr; 193(1):99-107. PubMed ID: 10202117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in cytokine secretion induced by altered peptide ligands of myelin basic protein peptide 85-99.
    Ausubel LJ; Krieger JI; Hafler DA
    J Immunol; 1997 Sep; 159(5):2502-12. PubMed ID: 9278344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-DR2a is the dominant restriction molecule for the cytotoxic T cell response to myelin basic protein in DR2Dw2 individuals.
    Jaraquemada D; Martin R; Rosen-Bronson S; Flerlage M; McFarland HF; Long EO
    J Immunol; 1990 Nov; 145(9):2880-5. PubMed ID: 1698864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis.
    Ota K; Matsui M; Milford EL; Mackin GA; Weiner HL; Hafler DA
    Nature; 1990 Jul; 346(6280):183-7. PubMed ID: 1694970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA restriction and TCR usage of T lymphocytes specific for a novel candidate autoantigen, X2 MBP, in multiple sclerosis.
    Voskuhl RR; Robinson ED; Segal BM; Tranquill L; Camphausen K; Albert PS; Richert JR; McFarland HF
    J Immunol; 1994 Nov; 153(10):4834-44. PubMed ID: 7525716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fine specificity of the myelin-reactive T cell repertoire: implications for TCR antagonism in autoimmunity.
    Anderton SM; Manickasingham SP; Burkhart C; Luckcuck TA; Holland SJ; Lamont AG; Wraith DC
    J Immunol; 1998 Oct; 161(7):3357-64. PubMed ID: 9759852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonal expansion and persistence of human T cells specific for an immunodominant myelin basic protein peptide.
    Wucherpfennig KW; Zhang J; Witek C; Matsui M; Modabber Y; Ota K; Hafler DA
    J Immunol; 1994 Jun; 152(11):5581-92. PubMed ID: 7514641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of CD28 engagement and IL-12 on T cell activation by altered peptide ligands.
    Ding L; Shevach EM
    J Immunol; 1998 Dec; 161(12):6614-21. PubMed ID: 9862689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantigen recognition by human CD8 T cell clones: enhanced agonist response induced by altered peptide ligands.
    Dressel A; Chin JL; Sette A; Gausling R; Höllsberg P; Hafler DA
    J Immunol; 1997 Nov; 159(10):4943-51. PubMed ID: 9366420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diversity of T cell receptor alpha and beta chain genes expressed by human T cells specific for similar myelin basic protein peptide/major histocompatibility complexes.
    Giegerich G; Pette M; Meinl E; Epplen JT; Wekerle H; Hinkkanen A
    Eur J Immunol; 1992 Mar; 22(3):753-8. PubMed ID: 1372258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specificity of human T cell clones reactive to immunodominant epitopes of myelin basic protein.
    Chou YK; Henderikx P; Vainiene M; Whitham R; Bourdette D; Chou CH; Hashim G; Offner H; Vandenbark AA
    J Neurosci Res; 1991 Feb; 28(2):280-90. PubMed ID: 1709690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-cell presentation of antigen requires cell-to-cell contact for proliferation and anergy induction. Differential MHC requirements for superantigen and autoantigen.
    LaSalle JM; Toneguzzo F; Saadeh M; Golan DE; Taber R; Hafler DA
    J Immunol; 1993 Jul; 151(2):649-57. PubMed ID: 7687620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphic residues on the I-A beta chain modulate the stimulation of T cell clones specific for the N-terminal peptide of the autoantigen myelin basic protein.
    Davis CB; Mitchell DJ; Wraith DC; Todd JA; Zamvil SS; McDevitt HO; Steinman L; Jones PP
    J Immunol; 1989 Oct; 143(7):2083-93. PubMed ID: 2476496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular interactions between transfected human TCR, immunodominant myelin basic protein peptide 152-165, and HLA-DR13.
    Hastings AE; Hurley CK; Robinson ED; Salerno K; Hernandez E; Richert JR
    J Immunol; 1996 Oct; 157(8):3460-71. PubMed ID: 8871645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.